Using Adhesive Biosensor Patches to Characterize the Biochemical Phenotype in PTSD
NCT ID: NCT04071132
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2019-08-31
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The current study is a non-interventional observational study aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biochemical and Physiological Response to Stressogenic Stimuli
NCT04076215
An Advanced Digital Phenotype System Among People Suffering From Post-traumatic Stress Disorder
NCT03788278
Biological Markers for Post-Traumatic Stress Disorder
NCT05213858
Context Sensitivity in Emotion Regulation in Post-Traumatic Stress Disorder
NCT06007612
Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD
NCT05717439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants diagnosed with PTSD
No interventions assigned to this group
Non-PTSD participants
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proper ability to give informed consent
Exclusion Criteria
* Active/terminal oncological condition
* Dialysis patients
* Pregnancy
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nadav Goldental
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadav Goldental
Principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6381-19-SMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.